Ikarian Capital »

Mind Medicine Mindmed shares owned by Ikarian Capital

Quarter-by-quarter ownership of Mind Medicine Mindmed (MNMD) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Mind Medicine Mindmed

Tip: Access up to 7 years of quarterly data

All positions including Mind Medicine Mindmed held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mind Medicine Mindmed by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.2M 600k 3.66

More positions owned by Ikarian Capital

Argenx Se Sponsored Adr (ARGX)
Krystal Biotech Call Option (KRYS)
Cytokinetics Com New (CYTK)
Alnylam Pharmaceuticals Call Option (ALNY)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Crispr Therapeutics Namen Akt (CRSP)
Eli Lilly & Co. Put Option (LLY)
Sarepta Therapeutics (SRPT)
Prothena Corp SHS Call Option (PRTA)
Amylyx Pharmaceuticals (AMLX)
Nuvalent Inc-a (NUVL)
Immunovant (IMVT)
Crinetics Pharmaceuticals In (CRNX)
Soleno Therapeutics (SLNO)
Eyepoint Pharmaceuticals Com New (EYPT)

View all positions for Ikarian Capital

Top funds holding Mind Medicine Mindmed

Susquehanna International
BlackRock
Ikarian Capital
Vanguard Group
Geode Capital Management
Citadel Advisors
Hrt Financial
Charles Schwab Investment Management
Moloney Securities Asset Management
Two Sigma Investments
Scotia Capital
Qube Research & Technologies
Goldman Sachs Group
Citigroup
Jane Street

View all funds holding Mind Medicine Mindmed